Resumen

BASANTE, Roberto et al. Evidence-based guideline for anticoagulant management of Electrophysiology procedures. Rev. Colomb. Cardiol. [online]. 2023, vol.30, n.6, pp.353-360.  Epub 04-Ene-2024. ISSN 0120-5633.  https://doi.org/10.24875/rccar.22000050.

Perioperative management of patients undergoing electrophysiology procedures is challenging, as many of these patients have a high background embolic risk and are often on oral anticoagulant therapy. The decision to continue, discontinue oral anticoagulation, or indicate bridging therapy is controversial. This article aims to generate evidence-based recommendations on the perioperative management of anticoagulation in patients who, due to their embolic risk, require oral anticoagulation with and will undergo cardiac pacing device implantation or arrhythmia ablation. A systematic review has been carried out following the criteria of the PRISMA protocol. The search was performed in the MEDLINE-PubMed, Embase, Cochrane, Google Scholar, NICE, Epistemonikos and LILACS databases. This systematic review included clinical practice guidelines, systematic reviews of the literature, and meta-analyses. The evidence was updated from January 1, 2014 to February 28, 2022. 3 CPG and 4 RSL were taken as a body of evidence, which were qualified with the AGREE II and AMSTAR II instruments, respectively. Evidence-based recommendations, using the GRADE methodology, are generated which highlight that oral anticoagulation with vitamin K antagonists should be ordered continuously for both atrial fibrillation (AF) ablation and device implantation, and continuously for DOAC in arrhythmia ablation; however, there is not much evidence on direct oral anticoagulation in device implantation.

Palabras clave : Cardiac implantable electronic devices; Catheter ablation; Periprocedural Anticoagulation.

        · resumen en Español     · texto en Español     · Español ( pdf )